Breast cancer - capecitabine (replaced by CG81)
Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer
Summary
This guidance has been updated and replaced by CG81 Advanced breast cancer.
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA62
Issued: May 2003
How this guidance was produced